Ishan Jain

Founder, YRI | Angel Investor | ISEF Finalist | Published Researcher (10+ Papers) | Helping Students Become Published Scientists at the YRI Fellowship

San Francisco Bay Area

About

I used to think winning major science fairs required luck or elite connections. I was wrong. Winning is a system. I cracked the code. I became a Regeneron ISEF Finalist and published 10+ peer-reviewed papers. Taking that exact blueprint, I built the YRI Fellowship. I built it because I wished a system like this existed when I was a student. Now, those same results are repeating for my students. Many join with zero research experience Within months, they are becoming ISEF finalists, filing patents, and getting published in journals like IEEE and Springer Nature. Our fellowship currently maintains a 90%+ publication rate. They don't work harder than you. They follow a pattern. A strategy. Stop wasting your limited school years on failed projects. Become a published researcher and science fair winner with the PROVEN blueprint. Apply here: yriscience.com

Experience

  • CEO, Founder at YRI
    Apr 2025 - Present · 1 yr 3 mos

    YRI Fellowship: yriscience.com

  • Quantitative Developer at Prismatic Capital
    Jan 2024 - Jan 2025 · 1 yr 1 mo

    AI trading strategies and performance evaluation.

  • Stanford University School of Medicine (1 yr 5 mos)
    • Lead Developer
      Feb 2020 - Jun 2021 · 1 yr 5 mos

      Developed opioid overdose prevention mobile app w/ the US Department of Veterans Affairs.

    • Paid Research Intern
      May 2020 - Sep 2020 · 5 mos

      AI/NLP algorithms to evaluate IBD treatments.

  • Cedars-Sinai (Los Angeles, California, United States)
    • Computer Vision Research Scientist
      Feb 2021 - Apr 2021 · 3 mos

      Heart failure diagnosis tool using AI.

    • AI Researcher
      May 2020 - Mar 2021 · 11 mos

      Clinical error in workflow assessment.

  • Research Intern at Stony Brook University
    Jun 2020 - Aug 2020 · 3 mos

    Funded by NASA. Assessed lunar regolith simulant toxicity on human lung cells.